Relyvrio

sodium phenylbutyrate/taurursodiol

Approval

ApplicationNDA 216660
Approval dateSep 29, 2022
Approval year2022
SponsorAmylyx

FDA-approved use

To treat amyotrophic lateral sclerosis (ALS)

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Relyvrio: